Starium Innovative Healthcare
| Private | |
| ISIN | 🆔 |
| Industry | Pharmaceuticals |
| Founded 📆 | 2021 |
| Founder 👔 | Hrishikesh Bhargava[1] |
| Headquarters 🏙️ | , , India |
Area served 🗺️ | |
Key people | Hrishikesh Bhargava (Executive Chairman) Sakshi Vaidya (MD) |
| Products 📟 | Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health |
| Revenue🤑 | |
| Members | |
Number of employees | 15 (2021) |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
Starium Innovative Healthcare is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India and globally.
Company
Starium set up its research and development facility for ANDA development at Taloja in 2021. In 2022, the anti-infective drug Taxim of Starium became the first anti-infective drug in the Indian pharmaceutical industry to cross 1 million in terms of domestic sales in India.
Governance and administration
Hrishikesh Bhargava is the founder and chairman of the company; he led and shaped Starium into what it is today. He has a B.Tech degree from Oriental Institute of Science and Technology. His brother, Kanhaiya Singh, is also the co-founder of the company.
References
- ↑ "List of Top Largest Pharmaceutical Companies in India [Updated 2022-2023]". NBC4i. 2022-12-26. Retrieved 2022-12-26.
- ↑ "Bestseller partners Starium Innovative Healthcare to sell Healthcare brands online".
References
This article "Starium Innovative Healthcare" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Starium Innovative Healthcare. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
